Cargando…
Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome
Objective: Clinical characteristics of immune thrombocytopenia (ITP) associated with primary Sjögren's syndrome (pSS) have not been clearly defined. This study aimed to evaluate the prevalence and clinical characteristics of secondary ITP in patients with pSS. Methods: 291 pSS patients in our h...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181055/ https://www.ncbi.nlm.nih.gov/pubmed/32363196 http://dx.doi.org/10.3389/fmed.2020.00138 |
_version_ | 1783525964379062272 |
---|---|
author | Dai, Fan Yang, Guomei Rao, Peishi Wu, Puqi Chen, Rongjuan Sun, Yuechi Peng, Yun Qian, Hongyan Wang, Bin Chen, Shiju Liu, Yuan Shi, Guixiu |
author_facet | Dai, Fan Yang, Guomei Rao, Peishi Wu, Puqi Chen, Rongjuan Sun, Yuechi Peng, Yun Qian, Hongyan Wang, Bin Chen, Shiju Liu, Yuan Shi, Guixiu |
author_sort | Dai, Fan |
collection | PubMed |
description | Objective: Clinical characteristics of immune thrombocytopenia (ITP) associated with primary Sjögren's syndrome (pSS) have not been clearly defined. This study aimed to evaluate the prevalence and clinical characteristics of secondary ITP in patients with pSS. Methods: 291 pSS patients in our hospital were retrospectively analyzed. Clinical manifestations and laboratory findings were compared between pSS patients with and without ITP. Results: The prevalence of secondary ITP in pSS patients was 12.03%. Compared to pSS patients without ITP, pSS patients with ITP were younger and had higher disease activity. The prevalence of interstitial lung diseases (ILD) was significantly lower in pSS patients with ITP (30.43 vs. 54.95%; P = 0.029), and it was the same with arthritis (17.14 vs. 3.9.11%; P = 0.014) and dry eye (33.33 vs. 54.17%, P = 0.027) compared with those without ITP. Serum creatinine level was lower in pSS patients with ITP (P = 0.009), while positivity of anti-histone autoantibodies was higher in pSS patients with ITP (P = 0.025). Conclusion: This study is an initial report describing clinical features of ITP in pSS. The lower incidence of ILD and arthritis among pSS patients with ITP indicated potential active roles of platelets in the pathogenesis of fibrosis or inflammatory arthritis, which may open the way for further experimental and clinical work. |
format | Online Article Text |
id | pubmed-7181055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71810552020-05-01 Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome Dai, Fan Yang, Guomei Rao, Peishi Wu, Puqi Chen, Rongjuan Sun, Yuechi Peng, Yun Qian, Hongyan Wang, Bin Chen, Shiju Liu, Yuan Shi, Guixiu Front Med (Lausanne) Medicine Objective: Clinical characteristics of immune thrombocytopenia (ITP) associated with primary Sjögren's syndrome (pSS) have not been clearly defined. This study aimed to evaluate the prevalence and clinical characteristics of secondary ITP in patients with pSS. Methods: 291 pSS patients in our hospital were retrospectively analyzed. Clinical manifestations and laboratory findings were compared between pSS patients with and without ITP. Results: The prevalence of secondary ITP in pSS patients was 12.03%. Compared to pSS patients without ITP, pSS patients with ITP were younger and had higher disease activity. The prevalence of interstitial lung diseases (ILD) was significantly lower in pSS patients with ITP (30.43 vs. 54.95%; P = 0.029), and it was the same with arthritis (17.14 vs. 3.9.11%; P = 0.014) and dry eye (33.33 vs. 54.17%, P = 0.027) compared with those without ITP. Serum creatinine level was lower in pSS patients with ITP (P = 0.009), while positivity of anti-histone autoantibodies was higher in pSS patients with ITP (P = 0.025). Conclusion: This study is an initial report describing clinical features of ITP in pSS. The lower incidence of ILD and arthritis among pSS patients with ITP indicated potential active roles of platelets in the pathogenesis of fibrosis or inflammatory arthritis, which may open the way for further experimental and clinical work. Frontiers Media S.A. 2020-04-17 /pmc/articles/PMC7181055/ /pubmed/32363196 http://dx.doi.org/10.3389/fmed.2020.00138 Text en Copyright © 2020 Dai, Yang, Rao, Wu, Chen, Sun, Peng, Qian, Wang, Chen, Liu and Shi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Dai, Fan Yang, Guomei Rao, Peishi Wu, Puqi Chen, Rongjuan Sun, Yuechi Peng, Yun Qian, Hongyan Wang, Bin Chen, Shiju Liu, Yuan Shi, Guixiu Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome |
title | Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome |
title_full | Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome |
title_fullStr | Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome |
title_full_unstemmed | Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome |
title_short | Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome |
title_sort | clinical characteristics of secondary immune thrombocytopenia associated with primary sjögren's syndrome |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181055/ https://www.ncbi.nlm.nih.gov/pubmed/32363196 http://dx.doi.org/10.3389/fmed.2020.00138 |
work_keys_str_mv | AT daifan clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT yangguomei clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT raopeishi clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT wupuqi clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT chenrongjuan clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT sunyuechi clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT pengyun clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT qianhongyan clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT wangbin clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT chenshiju clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT liuyuan clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome AT shiguixiu clinicalcharacteristicsofsecondaryimmunethrombocytopeniaassociatedwithprimarysjogrenssyndrome |